FMR LLC 13D and 13G filings for Acceleron Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-11-10 12:24 pm Sale | 2021-11-09 | 13G | Acceleron Pharma Inc. XLRN | FMR LLC | 493,493 0.807% | -4,184,920![]() (-89.45%) | Filing |
2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Acceleron Pharma Inc. XLRN | FMR LLC | 4,678,413 7.764% | -1,208,250![]() (-20.53%) | Filing |
2020-09-10 10:03 am Sale | 2020-09-09 | 13G | Acceleron Pharma Inc. XLRN | FMR LLC | 5,886,663 9.828% | -2,075,571![]() (-26.07%) | Filing |